About this trial
Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or death
Study Intervention: Multi-component Digital Health Solutions, including:
1. Computerized Clinical Decision Support (CDS) and 2. Virtual Care Delivered through Hospital at Home (VC) Duration of administration: Determined by the Patient's clinical team Reference therapy: Usual Care Statistical Analyses: Descriptive Analysis, Regression
Eligibility criteria
Qualifiers
Age ≥ 18 years old.
AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17.
Hospitalization > 48 hours.
LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or higher.
Disqualifiers
Non-Alberta residents.
Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs.
C1 or C2 goals of care.
Hospitalization > 30 days.
Trial design
Treatments tested in this trial
- Virtual Care
Treatment groups
Sponsors and collaborators
University of Calgary
Lead sponsor
Alberta Health services
Collaborator